Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum

Journal of Neurochemistry

Volumn 76, Issue 4, 2001, Pages 990-997

  Roceri, Mila ^a,b   Molteni, Raffaella ^a   Fumagalli, Fabio ^a   Racagni, Giorgio ^a,b   Gennarelli, Massimo ^b   Corsini, Giovanni U ^c   Maggio, Roberto ^c   Riva, Marco A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Gene expression; Glutamate; Neuroprotection; Neurotrophic factor; Parkinson's disease

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FIBROBLAST GROWTH FACTOR 2; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIC FACTOR; NICOTINE; QUINPIROLE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; GENE EXPRESSION SYSTEM; MALE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FIBROBLAST GROWTH FACTOR 2; HALOPERIDOL; MALE; NICOTINE; NICOTINIC AGONISTS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; STEREOISOMERISM;

ANIMALIA;

EID: 0035116876     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00088.x     Document Type: Article

References (49)

1. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
3. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo
4. Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system
5. Fibroblast growth factors: Activities and significance of non-neurotrophin neurotrophic growth factors
6. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human
7. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat
8. The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions
9. Biological roles of fibroblast growth factor-2
10. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbraln of the intact but not of the 6-hydroxydopamine-lesioned rat
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
12. Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat
13. Nicotinic binding in rat brain: Autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [1251]-alpha-bungarotoxin
14. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): An insight into an intracrine mechanism
15. Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons
16. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity
17. Neuronal nicotinic receptors: Molecular organization and regulations
18. Basic FGF in adult rat brain: Cellular distribution and response to entorhinal lesion and fimbria-fornix transection
19. Neurotrophic factor therapy for nervous system degenerative diseases
20. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: Role of nicotinic receptors in the ventral tegmental area
21. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse
22. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation
23. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury
24. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors
25. Nicotine protects cultured striatal neurones against N-methyl-Daspartate receptor-mediated neurotoxicity
26. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats
27. Fibroblast growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal neuroarchitecture
28. Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system
29. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats
30. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia
31. NMDA antagonists as neurotherapeufic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia
32. NMDA antagonist neurotoxicity: Mechanism and prevention
33. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice
34. Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture
35. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism
36. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons
37. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures
38. Short- and long-term induction of basic fibroblast growth factor gene expression in rat central nervous system following kainate injection
39. Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: Comparison with fibroblast growth factor-1 and ciliary neurotrophic factor
40. Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats
41. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease
42. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors
43. High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain
44. Seizure-associated induction of basic fibroblast growth factor and its receptor in the rat brain
45. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells
46. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions
47. Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization
48. Presynaptic nicotinic ACh receptors
49. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction